FDA recommends that partnerships should be used to better monitor medical device performance once released. The article states knee replacements as an example of an area that uses multiple different medical devices, yet the performance information has not been...
Pearl Pathways is excited to announce the addition of Mary Anne Gfell to the team as a Clinical Research Advisor. Bringing over 15 years of experience in clinical research and quality compliance, Gfell is a key addition to the Pearl Pathways team. Prior to joining...
According to a recent article in News-Medical.net, the Sunshine Act’s new Open Payments plan could potentially be the cause of a dramatic downfall in U.S. clinical research. Research conducted from the U.S. Open Payments database has shown that between 2013 and 2014,...
Every so often, clinical tries are said to ‘fail’, but can the trial actually fail? According to John Lechleiter, President and CEO of Eli Lilly and Company, “a clinical trial is a failure only if we can’t learn from it.” He believes that no matter how a clinical...
Recently, Cedars-Sinai “Research for Her” advanced its clinical research study participation registry matching women with research studies and clinical trials. The results included more participants and reduced registration time compared to paper based processes. “A...
